Rationale: Primary malignant melanoma of the esophagus (PMME) is a rare malignancy that only accounts for <2% of all primary esophageal tumors. Here, we report the even rarer occurrence of PMME in combination with poorly differentiated mucinous adenocarcinoma of the stomach.
Introduction
Malignant melanoma occurs mostly in the skin and primary malignant melanoma of the esophagus (PMME) is very rare, accounting for approximately 0.1% to 0.2% of all esophageal tumors and 0.5% of all noncutaneous melanomas. [1, 2] The average age of the patients with PMME is 60.5 years and the ratio of men to women is 2:1. [3] Along with the high aggressiveness of the disease, the median survival time of PMME is 13.4 months and 5-year overall survival rate is around 4%, [4, 5] the rate may be improved to 37.5% after surgical resection according to a recent study. [6] As the fourth most common malignancy and the second leading cause of cancer-related death worldwide, [7] gastric cancer is a serious problem to human health. Although both of the malignancies occur in digestive system, simultaneous occurrence of PMME and gastric adenocarcinoma has not been reported in China or elsewhere. Here, we report a case of PMME combined with poorly differentiated gastric mucinous adenocarcinoma and a review of the relevant literature. Our case suggests that comprehensive examinations before surgery are of vital importance to diagnosis and double primary malignancies indicate poor prognosis.
Case presentation
The patient was a nonsmoking 64-year-old man who had been admitted to a primary care unit because of >1 month of eating dysphagia. Gastroscopy showed a black protuberant lesion and chronic erosive gastritis. The patient then went to our hospital for further diagnosis and treatment. Pulmonary contrastenhanced computed tomography (CT) showed a spaceoccupying lesion in the lower esophagus with moderate enhancement (Fig. 1) . No other tumor or lymph node involvement was seen based on total body CT scan. Gastroscopy showed 2 black masses in the esophagus located at 22 to 24 cm and 30 to 35 cm, respectively, from the incisors that led to esophageal narrowing ( Fig. 2A) . Moreover, a 2.0 cm ulcer was observed in the posterior wall of the lower part of the stomach, and the surrounding mucosa showed nodular changes (Fig. 2B ). Endoscopic ultrasonography detected abundant blood flow signals at the lesions of esophagus (Fig. 2C) . Endoscopic biopsy was not performed in case of bleeding. The pathological findings for the gastric body revealed poorly differentiated mucinous adenocarcinoma. The clinical diagnosis was firstly made as poorly differentiated stomach adenocarcinoma and esophageal tumor. After discussion by a multidisciplinary treatment group including departments of thoracic and gastrointestinal surgery, the patient underwent laparoscopic gastric cancer radical surgery, esophageal resection, and colonic replacement of the esophagus under general anesthesia.
Macroscopically, the esophageal tumors were scattered distributed, the biggest tumor was 7.5 Â 3.0 Â 0.8 cm in dimension. The cut surface was reddish brown, solid, and tough. Scattered black nodules (the diameter was around 0.2-1.0 cm; Fig. 3A) were observed in the surface of the esophageal mucosa. The gastric body near the lesser curvature showed a 2.0 Â 1.5 Â 0.4 cm anabrosis, and the cut surface was light brown, solid, and tough (Fig. 3B ). Microscopic examination of the gastric body showed poorly differentiated mucinous adenocarcinoma; signet ring cells could also be seen. Superficial muscularis propria was invaded, but metastasis of lymph node was not observed (Fig. 4A ). Malignant melanoma infiltration was seen in the esophagus and submucosa was invaded with no lymph node involved (Fig. 4B ). Both were primary malignant tumors. Immunohistochemistry staining of the stomach showed CKpan (+), Ki-67 (+50%), P53 (+<5%), and Her-2 (+) (Fig. 5A) , as well as S-100 (±) for the lymph nodes. Immunohistochemistry staining of the esophagus demonstrated Ki-67 (+40%), Melan-A (+) (Fig. 5B ), HMB45 (+) (Fig. 5C ), CD117 (+), S-100 (+) (Fig. 5D ), CK-pan (-), CK5/6 (À), P63 (À), Vimentin (À), and Dog-1 (À). The patient was diagnosed with esophageal malignant melanoma and poorly differentiated gastric mucinous adenocarcinoma. The stage of gastric adenocarcinoma was classified as IB (pT2N0M0), according to the American Joint Commission on Cancer (AJCC) Cancer Staging Manual (8th Edition). The stage of PMME is uncertain because there is no standard staging for PMME as far as we know, and using TNM stage of esophageal cancer or cutaneous melanoma is not accurate in such case. One week after surgery, results of abdominal CT and esophagography were consistent with postoperative changes without any other abnormalities. Two weeks after surgery, chest drainage, mediastinal drainage, and gastric tube were removed, and the patient could start to eat a small amount of liquid food. The patient was discharged with good condition 3 weeks after surgery. Neither radiotherapy nor chemotherapy was performed after surgery, and the patient died after 3 months of follow-up. The patient and his family provided informed consent for this case report. On the contrary, our case does not need ethical approval from ethics committee or institutional review board. 
Discussion
Melanoma is a highly aggressive malignancy that mainly occurs at skin. As a noncutaneous melanoma, PMME has been occasionally reported since 1906. [2] To date, about 337 cases of esophageal melanoma have been published, [4, 8] whereas copresentation with gastric cancer has not been reported.
Little has been discussed about the etiology of PMME. Over 80% of the PMME located in the lower and middle thirds of the esophagus because a large number of melanocytes gathered in the location, [2] which was consistent with our observation in this case. It has been indicated that the esophageal melanocytosis is a precancerous lesion of PMME, [9, 10] and esophageal melanocytic dysplasia will eventually develop into PMME. [8, 11] The diagnosis of esophageal melanoma is often difficult because it mainly depends on clinical manifestations, endoscopy, and pathology. The clinical manifestations of PMME are not significantly different from other tumors of the esophagus. The most common symptoms is progressive dysphagia [5] as well as, in our case, other symptoms include antiacid, heartburn, retrosternal pain, hematemesis, black stool, and weight loss, whereas a few patients are asymptomatic at diagnosis. [3, [12] [13] [14] The shape of the tumor can be polypoid, nodular, beaded, or cauliflower-like. In 85% of cases, the lesions had pale, brown, blue, black, or darkbrown pigmentation. [15] Gastroscopy always showed that the lesions were accompanied by ulceration or satellite nodules, which were fragile and easily bled. These were all in consistency with our findings. Although the accuracy rate of diagnosis by biopsy is approximately 80%, [16] we did not perform biopsy in our case because endoscopic ultrasonography showed abundant blood flow signals and biopsy might lead to bleeding. Besides, Figure 3 . A macroscopic view of the cut-end surfaces of the resected specimens. (A) The surgical specimen showed a cauliflower-like bulge (7.5 Â 3.0 Â 0.8 cm in dimension) on the surface of esophagus, which was reddish brown, solid, and tough. In the mucosa of the esophageal, we observed scattered black brown nodules. (B) The gastric body near the lesser curvature showed an anabrosis (2.0 Â 1.5 Â 0.4 cm in dimension), and the section was light brown, solid, and tough. sometimes the tumors are amelanotic with no melanin granules, concentrated in foci or covered by normal squamous epithelium, which might influence the accuracy of endoscopic biopsy and lead to misdiagnosis. [2, 5, 17] If histological diagnosis is uncertain, immune-related markers such as S-100 protein, HMB-45, and Melan-A should be performed to improve the accuracy of the diagnosis [3, 18] owing to the high sensitivity of S-100 and high specificity of HMB-45 and Melan-A in melanomas. [4] The pathological results in our case confirmed our diagnosis.
There is no standard strategy for the treatment of PMME. The studies on the effects of radiotherapy, chemotherapy, and immunotherapy were inconsistent; some cases reported survival benefits [19] [20] [21] [22] [23] ; and others did not reach the same conclusion. [2, 5, 24] Currently, the main treatment for PMME is surgical excision. [3] Radical resection is also the main treatment for early poorly differentiated stomach adenocarcinoma. Although 2 malignant tumors were treated by surgical resection in our case, the patient died 3 months after surgery. The most important prognostic factor noted in the literature is lymph node metastasis, [25] which correlates with worse prognosis. [26] However, based on our experience with this case, lymph node metastasis is not a decisive factor in prognosis, the double malignancy may have significantly reduced the survival time.
In conclusion, the cooccurrence of poorly differentiated gastric adenocarcinoma greatly worsens the prognosis and reduces survival time. Comprehensive examinations should be performed to make the accurate diagnosis. Endoscopic ultrasonography might be useful to diagnose PMME and avoid unnecessary bleeding. The clinical features, endoscopic examinations, and pathological diagnosis of this case may provide important clinical guidance for clinicians developing individualized treatment plans for specific patients. , and (D) S-100 (+) (magnification: 100Â) in PMME. IHC = immunohistochemistry, GC = gastric cancer, PMME = malignant melanoma of the esophagus. PMME = primary malignant melanoma of the esophagus. 
